about
Towards a unifying, systems biology understanding of large-scale cellular death and destruction caused by poorly liganded iron: Parkinson's, Huntington's, Alzheimer's, prions, bactericides, chemical toxicology and others as examplesHereditary hemochromatosis in the post-HFE eraPorphyria cutanea tarda as a complication of therapy for chronic hepatitis CAccelerated CCl4-induced liver fibrosis in Hjv-/- mice, associated with an oxidative burst and precocious profibrogenic gene expressionIron increases HMOX1 and decreases hepatitis C viral expression in HCV-expressing cellsRole of iron in hepatic fibrosis: one piece in the puzzlePhlebotomy improves histology in chronic hepatitis C males with mild iron overload.Metabolic response to iron deficiency in Saccharomyces cerevisiae.Effects of a single dose of oral iron on hepcidin concentrations in human urine and serum analyzed by a robust LC-MS/MS methodHepatocellular carcinoma in nonalcoholic fatty liver: role of environmental and genetic factors.Hepatitis C, porphyria cutanea tarda and liver iron: an update.Iron regulator hepcidin exhibits antiviral activity against hepatitis C virus.Molecular heterogeneity of familial porphyria cutanea tarda in Spain: characterization of 10 novel mutations in the UROD gene.Iron levels in hepatocytes and portal tract cells predict progression and outcomes of patients with advanced chronic hepatitis C.Branched-chain amino acid supplementation reduces oxidative stress and prolongs survival in rats with advanced liver cirrhosisMinihepcidins are rationally designed small peptides that mimic hepcidin activity in mice and may be useful for the treatment of iron overloadHeterozygous beta-globin gene mutations as a risk factor for iron accumulation and liver fibrosis in chronic hepatitis CHFE gene in primary and secondary hepatic iron overload.Iron overload and cofactors with special reference to alcohol, hepatitis C virus infection and steatosis/insulin resistance.A precious metal: Iron, an essential nutrient for all cellsThe diversity of liver diseases among outpatient referrals for an elevated serum ferritin.Dietary patterns in Brazilian patients with nonalcoholic fatty liver disease: a cross-sectional studyThe myths and realities of hemochromatosis.Liver biopsy assessment in chronic viral hepatitis: a personal, practical approach.Major components of metabolic syndrome and nutritional intakes in different genotype of UCP2 -866G/A gene polymorphisms in patients with NAFLD.Genetic factors that affect nonalcoholic fatty liver disease: A systematic clinical review.The relationship between serum ferritin levels and electrocardiogram characteristics in acutely ill patientsDisorders associated with systemic or local iron overload: from pathophysiology to clinical practice.Porphyrin and heme metabolism and the porphyrias.Cutaneous porphyrias part II: treatment strategies.Iron metabolic disorder in chronic hepatitis C: insights from recent evidence.The serum hepcidin:ferritin ratio is a potential biomarker for cirrhosis.The prognostic value of changes in serum ferritin levels during therapy for hepatitis C virus infection.Hepatic iron overload is common in chronic hepatitis B and is more severe in patients coinfected with hepatitis D virus.Effect of gadolinium on hepatic fat quantification using multi-echo reconstruction technique with T2* correction and estimation.Simultaneous liver iron and fat measures by magnetic resonance imaging in patients with hyperferritinemia.Early changes in the liver-soluble proteome from mice fed a nonalcoholic steatohepatitis inducing diet.
P2860
Q24289511-67F855A9-1C91-4987-9314-40D92EE72DA7Q24646056-0084CF86-79E2-4CE8-B813-90E953382906Q24647490-936FD771-44EB-42A7-B790-AC34E10C4010Q27319418-C84A733F-02F4-46EF-8E90-5B9691C6658DQ27489764-E76FBED4-18B2-4E17-9A88-E818734E8EA5Q33344424-32EDFE6E-D99A-41B8-AE8A-B34834712225Q33629438-3B872539-0E3A-41C6-BA61-666A4DAAAD2AQ33824987-22609792-B375-44D7-936D-2E54EA75252EQ34003022-ABD11635-7DC0-495B-8BCA-902035EA20C1Q34255487-18A3B00D-828D-44D2-BDDC-2B3A12C503C9Q34268811-580324CA-26F9-4F37-BA52-DCE65B6FB896Q34460329-CFF94C0E-6E05-4462-AD92-F334C19DE305Q34649898-955B4713-2497-4BD9-8BA9-A03F54783276Q34851479-2BFBF06B-39EE-47E9-B62F-2E28B75A8FF2Q34922542-2C2B6465-9AAC-4CEE-805E-6EABD86DFD94Q35578602-07DCE4FD-3856-4516-A562-B1A694867618Q35929476-E9DAFF7E-3C28-4780-8BE7-A009C81DE024Q36177897-4AA9BD5B-0159-40FA-90DB-20D447B80F63Q36177903-4A9F1D2B-A919-41A3-9DD3-7BAAAAEC26E2Q36267869-79D18320-F9AB-4A23-846E-560F75F8EE0AQ36542780-DE000C5B-2AB0-468C-B279-D3CCBE8B9BF7Q36555004-1596F852-10EF-4EAC-9F6E-7752B283DE53Q36735467-CF1B4AC3-B4E3-4FAD-A0C1-06EA64541665Q36814301-2EA813FF-8B0E-4C7A-A323-5E3BEA74331EQ37006682-5EF0E10D-ED4A-4E0A-A298-01AF4399123BQ37146192-4341AFD4-DAA7-4F4B-882A-5665E41DAA54Q37680677-078A8322-51DA-44BA-9A66-88CD69300099Q37928941-A3168396-401D-40C2-BE2B-8EA6A1CE7A2DQ38110514-53DC4E57-7CEE-4162-9CED-A761DA3A9520Q38153429-6CC6AD2E-6D49-4578-A143-B834009E8DFFQ38548605-41843B71-7E35-4A0A-A07D-27E0F9672E12Q39606468-C66F9598-84E8-479A-84AC-0EABDCBBA76BQ43036782-2C7337CC-FCA2-4313-B5E4-AA4CB04C6B10Q45360466-24E4F310-876A-4559-814D-0E1D03291E92Q48737176-F6D50FB0-2BC7-40FD-945F-362985A05D02Q50967793-FC388A2A-0C3F-4619-AD97-A3205B5E4CAEQ51339526-2F643C87-4D0A-4ED3-80E2-8EB4CDAF7CE9
P2860
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Iron in nonhemochromatotic liver disorders.
@ast
Iron in nonhemochromatotic liver disorders.
@en
type
label
Iron in nonhemochromatotic liver disorders.
@ast
Iron in nonhemochromatotic liver disorders.
@en
prefLabel
Iron in nonhemochromatotic liver disorders.
@ast
Iron in nonhemochromatotic liver disorders.
@en
P356
P1476
Iron in nonhemochromatotic liver disorders.
@en
P2093
Herbert L Bonkovsky
Vamsee Alla
P304
P356
10.1055/S-2005-923317
P577
2005-11-01T00:00:00Z